Cardiovascular risk and sildenafil

American Journal of Cardiology

Volumn 86, Issue 2 SUPPL. 1, 2000, Pages 57-61

  Kloner, Robert A ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; SILDENAFIL;

CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DRUG EFFICACY; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; MALE; META ANALYSIS; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION;

EID: 0034691831     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00895-X     Document Type: Conference Paper

References (27)

1. Virag R., Bouilly P., Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 322:1985;181-184.
2. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B. Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study . J Urol. 151:1994;54-61.
3. Impotence. JAMA. 270:1993;83-90.
4. Muller J.E., Mittleman A., Maclure M., Sherwood J.B., Tofler G.H. Triggering myocardial infarction by sexual activity low absolute risk and prevention by regular physical exertion . JAMA. 275:1996;1405-1409.
5. DeBusk R.F. Sexual activity triggering myocardial infarction one less thing to worry about . JAMA. 275:1996;1447-1448.
6. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397-1404.
7. Kloner R.A., Jarow J. Erectile dysfunction and sildenafil citrate and cardiologists. Am J Cardiol. 83:1999;576-582.
8. Jarow J., Kloner R.A., Holmes A.M. Viagra. 1998;1-150 M. Evans and Company, Inc, New York.
9. Wallis R.M., Corbin J.D., Francis S.H., Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol. 83:(suppl):1999;3C-12C.
10. Conti C.R., Pepine C.J., Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol. 83:(suppl):1999;29C-34C.
11. Morales A., Gingell C., Collins M., Wicker P.A., Osterloh I.H. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res. 10:1998;69-74.
12. Kloner RA, Brown M and the Sildenafil Study Group. Safety of sildenafil citrate in men with erectile dysfunction taking multiple antihypertensive agents (abstract). Am J Hypertens 1999;12:37A.
13. Data on file, Pfizer Inc., 1999.
14. Zusman R.M., Morales A., Glasser D.B., Osterloh I.A. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol. 83:(suppl):1999;35C-44C.
15. Goldman S.A. Limitations and strengths of spontaneous reports data. Clin Ther. 20:(suppl C):1998;C40-C44.
16. Baum C., Kweder S.L., Anello C. The spontaneous reporting system in the United States. Strom B.L. Pharmacoepidemiology. 1994;124-137 John Wiley & Sons, New York.
17. Food and Drug Administration Website. Postmarketing safety of sildenafil citrate (Viagra). Available at http://www.fda.gov./cder/consumer info/viagra/safety3.htm. November 23, 1998.
18. Data on file with the Deptartment of Health and Human Services, 1999.
19. American Heart Association. 1998 Heart and Stroke: Statistical Update. Dallas, Texas: American Heart Association Monograph, 1997.
20. Health United States 1998. Hyattsville, Maryland: US National Center for Health Statistics, 1998.
21. National Center for Health Statistics Website at http://www.cdc.gov/nchswww/products/products.htm.
22. Cheitlin M.D., Hutter A.M., Brindis R.G., Ganz P., Kaul S., Russell R.O., Zusman R.M. ACC/AHA Expert Consensus Document. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol. 33:1999;273-282.
23. Jackson G., Benjamin N., Jackson N., Albern M.J. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 83:(suppl):1999;13C-20C.
24. Webb D.J., Freestone S., Allen M.J., Muirhead G.J. Sildenafil citrate and blood-pressure-lowering drugs results of drug interaction studies with an organic nitrate and a calcium antagonist . Am J Cardiol. 83:(suppl):1999;21C-28C.
25. Kloner R.A., Zusman R.M. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol. 84:1999;11N-17N.
26. Zusman R, Collins M. For the Sildenafil Study Group. Effect of sildenafil on blood pressure in men with erectile dysfunction taking concomitant antihypertensive medications (abstract). J Am Cardiol 1999;33(suppl A);238A.
27. Traverse J.H., Du R., Crampton M., Voss M., Lindstrom P., Bache R.J. Effect of sildenafil (Viagra) on coronary blood flow and hemodynamics during exercise (abstract). J Am Coll Cardiol. 33:(suppl A):1998;303A.